The DOI matches its Crossref record; 48 of the 53 references it cites were found in a registry or an index.
A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on
Open accessAbstract
The WHO just released in May 2022 a report on the state of the obesity pandemic in Europe, stating that 60% of citizens in the area of Europe are either overweight or obese, and highlighting the implications of the obesity pandemic, especially as it interacts with the COVID pandemic to create a twin pandemic, to increase morbidity and mortality. Obesity is a complex disease which has reached pandemic dimensions. The worldwide prevalence of obesity has nearly tripled since 1975, mainly due to the adoption of a progressively more sedentary lifestyle and the consumption of less healthy diets. We first report herein updated prevalence rates of overweight and obesity by sex, age, and region first in Europe, per the WHO report, and then worldwide between 1980 and 2019, as we analyze and present herein the data provided by the Global Burden of Disease Study. The prevalence of obesity is higher in women than in men of any age and the prevalence of both overweight and obesity increases with age and has reached their highest point between the ages of 50 to 65 years showing a slight downward trend afterwards. The age-standardized prevalence of obesity has increased from 4.6% in 1980 to 14.0% in 2019. The American and European region have the highest obesity prevalence and the USA and Russia are the countries with the most obese residents. Given dire implications in terms of comorbidities and mortality, these updated epidemiological findings call for coordinated actions from local and regional governments, the scientific community and individual patients alike, as well as the food industry for the obesity pandemic to be controlled and alleviated. We can hopefully learn from the COVID-19 pandemic, where collaborative efforts worldwide, focused intense work at both the local and global level and well-coordinated leadership have demonstrated that humankind is capable of amazing accomplishments by leveraging science and public health, and that we can finally make strides in terms of understanding and combating the obesity pandemic and its dire comorbidities including diabetes, NAFLD, CVD and obesity associated malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity rates are rising globally, with the age-standardized prevalence increasing from 4.6% in 1980 to 14.0% in 2019 [1].”
From Beyond Calories: Individual Metabolic and Hormonal Adaptations Driving Variability in Weight Management—A State-of-the-Art Narrative Review (2024) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717 · cited 1×
“more central body fat distribution, these populations have [33].”
Health effects of overweight and obesity in 195 countries over 25 years
Collaborators, T. G. 2. O. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614362 · Cited by 7,918
Abarca-Gómez, L., Abdeen, Z. A., Hamid, Z. A., Abu-Rmeileh, N. M., Acosta-Cazares, B., Acuin, C., Adams, R. J., Aekplakorn, W., Afsana, K., Aguilar-Salinas, C. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32129-3 · Cited by 7,482
Obesity: global epidemiology and pathogenesis
Blüher, M. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0176-8 · Cited by 5,126 · cited 1×
“In addition, regional differences are largely associated with differences in socioeconomic status [30].”
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Body Fatness and Cancer — Viewpoint of the IARC Working Group
Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., & Straif, K. (2016) · New England Journal of Medicine · doi:10.1056/nejmsr1606602 · Cited by 3,596 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Chooi, Y. C., Ding, C., & Magkos, F. (2018) · Metabolism · doi:10.1016/j.metabol.2018.09.005 · Cited by 2,997 · cited 1×
“Obesity in the European region stating that both overweight and obesity rates have reached epidemic proportions across the European Region, where 59% of adults and almost 1 in 3 children are suffering from overweight or obesity [20], we publish this report as an update on the epidemiology of obesity [21].”
The Spirit Level: Why More Equal Societies Almost always do Better
Johnston, R. J. (2009) · Political Geography · doi:10.1016/j.polgeo.2009.10.003 · Cited by 2,054
The Emerging Risk Factors Collaboration (2011) · The Lancet · doi:10.1016/s0140-6736(11)60105-0 · Cited by 1,216 · cited 1×
“Epidemiologic studies have revealed an association between high body mass index (BMI) and an extensive range of chronic diseases such as Non Alcoholic Fatty Liver (NAFL), cardiovascular disease [1,2], diabetes mellitus [1], several malignancies [3,4], musculoskeletal diseases [5,6], chronic kidney disease [1], and men…”
Palaiodimos, L., Kokkinidis, D. G., Li, W., Karamanis, D., Ognibene, J., Arora, S., Southern, W. N., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154262 · Cited by 864
Self-citation
Research works printed but not linked: 1
- Angelidi, 2021, Novel non-invasive approaches to the treatment of obesity: from pharmacotherapy to gene therapy, Endocr Rev
Cited by
Sorted by citations
Items 101–200 of 1,001
Brown, J. M., Vandeveer, Z. T., Cadoret, D., Morrison, J., & Jahangiri, Y. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14062106 · Cited by 23
“This rise is partly attributed to the obesity epidemic, particularly in the United States, where obesity prevalence increased from 6.8% in 1980 to 22.4% in 2019, the highest rate globally [2].”
InfluentialDina, C., Ţiţ, D. M., Radu, A.-F., Bungau, G., & Radu, A.-F. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47060440 · Cited by 26
“The incidence of obesity peaks in the American and European regions, with Russia and the United States having the highest amount of obese individuals [17].”
Systematic Review of Machine Learning applied to the Prediction of Obesity and Overweight
Ferreras, A., Cano, S. S., Martínez‐Licort, R., Elío, I., Pifarré, K. T., Prola, T. A., Mazón, J. L. V., Sahelices, B., & Díez, I. D. L. T. (2023) · Journal of Medical Systems · doi:10.1007/s10916-022-01904-1 · Cited by 23
“In any case, it should not be forgotten that prevention is the best option to fight the obesity epidemic and that it requires the combined efforts of governments, the scientific community and the food industry to introduce the appropriate lifestyle changes to achieve this [7].”
Weight cycling based on altered immune microenvironment as a result of metaflammation
Li, W., & Chen, W. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00731-6 · Cited by 26
“In 2020, 39 million children under the age of five will be overweight or obese, and in 2022, the WHO estimates that approximately 60% of European adults will be overweight or obese [3].”
BackgroundLiu, H., Wang, G., Zhang, J., Lu, B., Li, D., & Chen, J. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.133570 · Cited by 23
Clinically Effective Molecules of Natural Origin for Obesity Prevention or Treatment
Hidalgo-Lozada, G. M., Villarruel‐López, A., Nuño, K., García, A. G., Sánchez-Nuño, Y. A., & Ramos-García, C. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052671 · Cited by 28
“Despite this, the general population still fails to fully grasp the severity of this metabolic disorder [2].”
BackgroundThe Role of Obesity in the Development of Preeclampsia
Schiavone, M. J., Pérez, M. P., Aquieri, A., Nosetto, D., María, P., Mazzei, M., Kudrle, C., & Avaca, H. A. (2024) · Current Hypertension Reports · doi:10.1007/s11906-024-01299-z · Cited by 23
“Worldwide prevalence of obesity nearly tripled between 1975 and 2023, mainly for the adoption of a progressively more sedentary lifestyle and the consumption of less healthy diets being worse for women than men [1].”
Liu, Y., Han, F., Xia, Z., Sun, P., Rohani, P., Amirthalingam, P., & Sohouli, M. H. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01319-7 · Cited by 23
“Obesity is a prevalently increasing chronic disease and a global epidemic [1].”
BackgroundBoyajian, J. L., Islam, P., Abosalha, A. K., Schaly, S., Thareja, R., Kassab, A., Arora, K., Santos, M., Shum-Tim, C., & Prakash, S. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.05 · Cited by 24
Salih, A. A., Arif, A., Varadpande, M., Fernandes, R. T., Janković, D., Kalasauskas, D., Ottenhausen, M., Kramer, A., Ringel, F. A., & Thavarajasingam, S. G. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102891 · Cited by 22
Adolescents’ Nutrition: The Role of Health Literacy, Family and Socio-Demographic Variables
Delbosq, S., Velasco, V., Vercesi, C., 2018, G. R. H. L., & Vecchio, L. P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315719 · Cited by 22
The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting
LORENZO, A. D., Pellegrini, M., Gualtieri, P., Itani, L., Ghoch, M. E., & Renzo, L. D. (2022) · Nutrients · doi:10.3390/nu14245295 · Cited by 22
“The World Health Organization (WHO) released a report on obesity prevalence in Europe in May 2022, stating that nearly 60% of citizens in this area are either affected by overweight or obesity [1].”
BackgroundBeneficial effects of Apelin-13 on metabolic diseases and exercise
Wen, R., Huang, R., Xu, K., Cheng, Y., & Yi, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1285788 · Cited by 23
Polden, M., Jones, A., Essman, M., Adams, J. M., Bishop, T. R. P., Burgoine, T., Donohue, A., Sharp, S. J., White, M. J., Smith, R., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-080405 · Cited by 22
“Furthermore, there was a significant interaction between time and IMD, specifically that outlets from IMD quintiles 2 and 5 showed a statistically significant larger increase in compliance scores compared with IMD1.”
ResultArias, C., Álvarez‐Indo, J., Cifuentes, M., Morselli, E., Kerr, B., & Burgos, P. V. (2024) · Biological Research · doi:10.1186/s40659-024-00531-z · Cited by 27
“Nowadays, obesity is considered as a global pandemic and the World Health Organization (WHO) reports that the rate of obesity has nearly tripled since 1975, currently affecting over one billion individuals globally [1, 2].”
BackgroundKendrick, K. N., Bode Padron, K. J., Bomani, N. Z., German, J. C., Nyanyo, D. D., Varriano, B., Tu, L., & Stanford, F. C. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.05.003 · Cited by 21
Preoperative Optimization Strategies in Elective Spine Surgery
Daniels, A. H., Singh, M., Knebel, A., Thomson, C. G., Kuharski, M. J., Varona-Cocero, A. D., Nassar, J. E., Farias, M. J., & Diebo, B. G. (2025) · JBJS Reviews · doi:10.2106/jbjs.rvw.24.00210 · Cited by 21
Obesity as a Disease: A Primer on Clinical and Physiological Insights
Shah, A., Davarci, O. O., Chaftari, P., & Avenatti, E. (2025) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1515 · Cited by 24
Lotfata, A., Georganos, S., Kalogirou, S., & Helbich, M. (2022) · ISPRS International Journal of Geo-Information · doi:10.3390/ijgi11110550 · Cited by 21
“The tract-level estimates, which are assessed in several prior studies [85,86], have certain limitations.”
BackgroundLeptin–VEGF crosstalk in excess body mass and related disorders: A systematic review
Skrypnik, D., Skrypnik, K., Suliburska, J., & Bogdański, P. (2023) · Obesity Reviews · doi:10.1111/obr.13575 · Cited by 21
“(WHO) report, excess body mass affects almost 60% of adult Europeans, 8% of children under 5, a third of school-aged children, and a quarter of children between 10 and 19 years of age.(2,3) In the United States, the annual cost of treating obesity ranges from 150 bil-”
BackgroundLandgraaf, R. G., Bloem, M. N., Fumagalli, M., Benninga, M. A., de Lorijn, F., & Nieuwdorp, M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1236370 · Cited by 21
“In addition, several studies have shown a link between high BMI and an extensive range of noncommunicable diseases (NCDs), such as cardiovascular disease, Type 2 Diabetes Mellitus (T2DM), several malignancies, musculoskeletal and rheumatological diseases, chronic kidney disease, acute respiratory infections like COVID…”
Jalil, J., Gabrielli, L., Ocaranza, M. P., MacNab, P., Fernández, R., Grassi, B. A., Jofré, P., Verdejo, H., Mónica Acevedo, B., Samuel Córdova, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084407 · Cited by 25
“As we age, both highest point between the trend [11].”
BackgroundHaggag, A. Z., Xu, J., Butcher, L., Pagnussat, S., Davies, G., Lundqvist, S., Wang, W., van Zuydam, N. R., Nelander, K., Jha, A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16047 · Cited by 21
van Kleef, L. A., Pustjens, J., Savas, M., Ayada, I., Li, P., Pan, Q., van Rossum, E. F. C., Janssen, H. L. A., & Brouwer, W. P. (2024) · Liver International · doi:10.1111/liv.16169 · Cited by 20
Lim, S. K., Buranapin, S., Bao, X., Quiroga, M., Park, K. H., Kang, J., Rinnov, A. R., & Suwanagool, A. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00164-0 · Cited by 22
A comprehensive review of genetic causes of obesity
Concepción‐Zavaleta, M. J., Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Osorio, E. R. G., de la Cruz, J. D. C. V., Barrueto-Callirgos, C. M., Puelles‐León, S. L., Alvarado-León, E. D. J., Cabrera, F. A. L., Zavaleta‐Gutiérrez, F. E., et al. (2023) · World Journal of Pediatrics · doi:10.1007/s12519-023-00757-z · Cited by 22
“Additionally, in South America, the prevalence of obesity among children under 5 years of age is 9%, and for those over 5 years of age, it rises to 12% [11].”
Metabolic changes with intermittent fasting
Lange, M. G., Coffey, A. A., Coleman, P. C., Barber, T. M., van Rens, T., Oyebode, O. O., Abbott, S., & Hanson, P. (2023) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.13253 · Cited by 26
Developmental programming of tissue-resident macrophages
Viola, M. F., Taveras, E. F., & Mass, E. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1475369 · Cited by 22
“However, the exponential increase in obesity and metabolic disorders in all regions of the world poses a novel and unprecedented challenge, as these disorders have shown to have wide-ranging consequences on offspring immune function (31).”
Bora, N., Vaishali, K., Verma, A., Bharti, A. K., & Sinha, M. K. (2024) · F1000Research · doi:10.12688/f1000research.152905.1 · Cited by 20
Luca, T., Pezzino, S., Puleo, S., & Castorina, S. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05547-3 · Cited by 19
“Moreover, in the same year, approximately 38.2 million children under 5 years of age and more than 340 million children aged 5 to 19 years were overweight or obese [10, 11].”
BackgroundInfluentialSzukiewicz, D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062501 · Cited by 23
“Over the past 25 to 30 years, the incidence of overweight and obesity has increased at an alarming rate, becoming a pandemic [6–8].”
Microbiome in heritage: how maternal microbiome transmission impacts next generation health
Delaroque, C., & Chassaing, B. (2025) · Microbiome · doi:10.1186/s40168-025-02186-8 · Cited by 23
Mount, S., Canfora, E. E., Jocken, J. W. E., Umanets, A., Hul, G. B. J., Coenjaerds, M. M. J., Laquidain, P. A., Adriaens, M. E., Holst, J. J., Jardon, K. M. C., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04394-7 · Cited by 25
“2 As leading contributors to mortality and substantial economic burden 3–5 , they underscore the urgent need for effective and sustainable weight management strategies.”
Li, Q., Wang, O., Ji, B., Zhao, L., & Zhao, L. (2023) · Nutrients · doi:10.3390/nu15132953 · Cited by 19
“Obesity is classified as a chronic disease, and the prevalence of obesity has almost trebled since 1975 [45].”
BackgroundPinsawas, B., Surawit, A., Mongkolsucharitkul, P., Pongkunakorn, T., Suta, S., Manosan, T., Ophakas, S., Pumeiam, S., Sranacharoenpong, K., & Mayurasakorn, K. (2024) · Journal of Nutrition · doi:10.1016/j.tjnut.2024.08.027 · Cited by 19
Zare, H., Rahimi, H., Omidi, A., Nematolahi, F., & Sharifi, N. (2024) · Nutrition Journal · doi:10.1186/s12937-024-01030-3 · Cited by 19
“This increase in the prevalence of obesity is more concerning among women [3].”
BackgroundZein, M. A., Akomolafe, A. F., Mahmood, F. R., Khrayzat, A., Sahebkar, A., Pintus, G., Kobeissy, F. H., & Eid, A. H. (2024) · Obesity Reviews · doi:10.1111/obr.13807 · Cited by 18
Reytor-González, C., Simancas‐Racines, D., Román-Galeano, N. M., Campuzano-Donoso, M., Am, C., Zambrano-Villacres, R., Teresa, M., Coppola, L., Marchetti, M., Galasso, M., et al. (2025) · Food and Agricultural Immunology · doi:10.1080/09540105.2025.2521270 · Cited by 21
“Obesity has emerged as one of the most pressing public health challenges of the twenty-first century, with global prevalence rates having nearly tripled since 1975 (Boutari & Mantzoros, 2022).”
Carral, J. M. C., Bezerra, P., Lopez-Rodriguez, A., & Silva, B. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.10.007 · Cited by 21
Amerikanou, C., Kleftaki, S.-A., Karavoltsos, S., Tagkouli, D., Sakellari, A., Valsamidou, E., Gioxari, A., Kalogeropoulos, N., & Kaliora, A. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1265310 · Cited by 18
Validation of the Sleepiz One + as a radar-based sensor for contactless diagnosis of sleep apnea
Gross-Isselmann, J. A., Eggert, T., Wildenauer, A., Dietz-Terjung, S., Sundrup, M. G., & Schoebel, C. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03057-6 · Cited by 19
“Growing numbers can be explained by improvements in diagnostic standards for OSA [3], and by the global rise of two important OSA risk factors: the steadily increase in obesity [4, 5] and life expectancy [6].”
BackgroundDopamine in the regulation of glucose and lipid metabolism: a narrative review
Li, Z., Zheng, L., Wang, J., Wang, L., Yao, Q., Amin, B., Zhu, J., & Zhang, N. (2024) · Obesity · doi:10.1002/oby.24068 · Cited by 17
“Owing to the worldwide spread of obesity, the incidence of metabolic disorders is on the rise [4].”
Li, Y., Zeng, Q., Peng, D., Hu, P., Luo, J., Zheng, K., Yin, Y., Si, R., Xiao, J., Li, S., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02393-6 · Cited by 18
Wen, J., Syed, B., Nadora, D., How‐Volkman, C., Bernstein, E., Truong, A., Akhtar, M., Razick, A., Puglisi, J., & Frezza, E. (2025) · Endocrinology, Diabetes & Metabolism · doi:10.1002/edm2.70045 · Cited by 17
Sallam, M., Snygg, J., Ghandour, S. E., & Sallam, M. (2025) · Obesities · doi:10.3390/obesities5020026 · Cited by 19
Singh, A., Verma, A., Ashraf, S., Sheikh, D. S., Irfan, H., Riaz, R., Venjhraj, F., Meghwar, S., Kumar, R., Tariq, M. D., et al. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000003656 · Cited by 18
“Gut microbiota play a crucial role in obesity, making them a key research focus for potential treatments [13] .”
Bultinck, J., Yuan, S., Cantuti‐Castelvetri, L., Brosens, L., Bracke, D., Collins, J., Goethals, J., Christianson, C. A., Nuss, J. M., & Ogilvie, K. M. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102282 · Cited by 18
“Worldwide, the incidence of obesity and associated comorbidities such as T2D, metabolic dysfunction-associated steatotic liver disease (MASLD), and CVD are expected to steadily rise [5,6].”
Harnessing GLP‐1 Receptor Agonists for Obesity Treatment: Prospects and Obstacles on the Horizon
Abdelrahman, R. M., Musa, T. H., Arbab, I. A., Suliman, M. H., Ahmed, E. O., Mohamed, A. N., Musa, H. H., Jalal, M., & Gasmallah, S. I. (2025) · Journal of Obesity · doi:10.1155/jobe/9919810 · Cited by 20
Navarrete, F. C., Jerez‐Mayorga, D., Álvarez, C., del‐Cuerpo, I., Barria, M. A. C., & Delgado‐Floody, P. (2023) · Nutrients · doi:10.3390/nu15112458 · Cited by 17
“Close to a third of the global population is considered overweight or obese [2]—it has almost tripled since 1975 [3]—whereas malnutrition by excess in Latin America is growing quickly compared with other continents [4], which increases the health and economic impact in the countries [5,6].”
BackgroundLow Adherence to Mediterranean Diet Characterizes Metabolic Patients with Gastrointestinal Cancer
Matteis, C. D., Crudele, L., Gadaleta, R. M., Buduo, E. D., Novielli, F., Petruzzelli, S., Cariello, M., & Moschetta, A. (2024) · Nutrients · doi:10.3390/nu16050630 · Cited by 17
“…is that patients who were enrolled in the study were referred to our clinic for metabolic-related assessment and not for cancer diagnosis or specific nutritional diseases; therefore, these patients can be considered a good example of the general population, considering the obesity pandemic [66].”
BackgroundLessons From Insulin: Policy Prescriptions for Affordable Diabetes and Obesity Medications
Nagel, K. E., Ramachandran, R., & Lipska, K. J. (2024) · Diabetes Care · doi:10.2337/dci23-0042 · Cited by 18
Multimetal exposure: Challenges in diagnostics, prevention, and treatment
Panghal, A., Thakur, A., Deore, M. S., Goyal, M., Singh, C., & Kumar, J. (2024) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23745 · Cited by 17
Lei, Y., Lei, X., Chen, G., Wang, Z., Song, H., Feng, X., Wu, Y., Jia, V., Hu, J., & Tian, Y. (2024) · BMC Surgery · doi:10.1186/s12893-024-02512-1 · Cited by 26
“The WHO released a report on obesity pandemic in Europe in May 2022, stating that 60% of citizens in Europe are with obesity [36].”
BackgroundThe Role of Obesity as a Cardiac Disease Risk Factor in Patients with Type 2 Diabetes
Koirala, S., Sunnaa, M., Bernier, T. D., & Oktay, A. A. (2024) · Current Cardiology Reports · doi:10.1007/s11886-024-02129-z · Cited by 17
“In the US alone, the prevalence of obesity has risen steadily from 12.8% in the 1960s to 41.9% in 2020 [11, 12].”
InfluentialMetabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
Lavens, A., Block, C. E. M. D., Oriot, P., Crenier, L., Philips, J., Vandenbroucke, M., Vanherwegen, A.-S., Nobels, F. R. E., Mathieu, C., & on behalf of the IQED Group of Experts (2024) · Diabetologia · doi:10.1007/s00125-024-06273-7 · Cited by 18
Zhan, Z., Chen, X., Xu, S., Li, Q., Yu, J., Guo, Z., & Chen, B. (2024) · World Journal of Surgical Oncology · doi:10.1186/s12957-024-03582-4 · Cited by 17
“As the rates of obesity continue to rise, particularly in developing countries like China, understanding the role of high BMI in GBTC incidence and mortality is essential for shaping public health policies and preventive strategies [12, 13].”
BackgroundLorek, D., Łupina, K., Bisaga, W., Malicki, D., Stępień, W., Kumor, L., & Janczura, J. (2025) · Korean Journal of Family Medicine · doi:10.4082/kjfm.25.0027 · Cited by 17
“This underscores the intricate connection between economic development and health behaviors, emphasizing the urgent need for comprehensive strategies to raise awareness and address all aspects of MASLD [4].”
Tsolakis, C. K., Cherouveim, E. D., Skouras, A. Z., Antonakis-Karamintzas, D., Czvekus, C., Halvatsiotis, P., Savvidou, O. D., & Koulouvaris, P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811476 · Cited by 17
“Among European countries where one of three children is overweight or obese, Greece has the highest prevalence [4,8,9].”
BackgroundDigital Footprints of Obesity Treatment: GLP-1 Receptor Agonists and the Health Equity Divide
Azizi, Z., Rodríguez, F., & Assimes, T. L. (2024) · Circulation · doi:10.1161/circulationaha.124.069680 · Cited by 17
Marin, R.-C., Radu, A.-F., Negru, P. A., Radu, A.-F., Negru, D. C., Aron, R. A. C., Bodog, T. M., Bodog, R. F., Maghiar, P. B., & Brata, R. D. (2024) · Medicina · doi:10.3390/medicina61010014 · Cited by 21
“Obesity is a complex disease that has reached pandemic proportions [8].”
Obesity and type 2 diabetes mellitus: insights from skeletal muscle extracellular matrix remodeling
Wu, L., & Coletta, D. K. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00154.2024 · Cited by 17
Why Are Obese People Predisposed to Severe Disease in Viral Respiratory Infections?
Aziz, R., Sherwani, A. Y., Mahri, S. A., Malik, S. S., & Mohammad, S. (2023) · Obesities · doi:10.3390/obesities3010005 · Cited by 16
“Instead of functioning alone, genes tend to combine with other risk factors, such as unhealthy diets and sedentary lifestyles, to increase the likelihood of weight gain and obesity [3].”
BackgroundAlbacete, S., Verhoeff, K. K., Mocanu, V., Birch, D. W., Karmali, S., & Switzer, N. J. (2023) · Surgical Endoscopy · doi:10.1007/s00464-023-10029-6 · Cited by 16
Liu, R., Qian, M., & Cui, Y. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155665 · Cited by 17
Insights into Nutritional Strategies in Psoriasis
Constantin, C., Surcel, M., Munteanu, A. N., & Neagu, M. T. (2023) · Nutrients · doi:10.3390/nu15163528 · Cited by 16
“The report highlights the cumulative inferences of the COVID-19 pandemic in respect of obesity, with all the repercussions that have resulted in terms of morbidity and mortality [11].”
BackgroundObesity and Extracorporeal Membrane Oxygenation (ECMO): Analysis of Outcomes
Ripoll, J. G., ElSaban, M., Nabzdyk, C. S., Balakrishna, A., Villavicencio, M. A., Calderon-Rojas, R. D., Ortoleva, J. P., Chang, M. G., Bittner, E. A., & Ramakrishna, H. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.10.025 · Cited by 16
Kumavath, R., Pavithran, H., Paul, S., Anju, V. T., Busi, S., & Dyavaiah, M. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5592 · Cited by 16
Food insecurity and body mass index among older people: A systematic review and meta-analysis
Gianfredi, V., Nucci, D., Lattanzio, R., Piccinelli, S., Cicconi, G., Santisteban, S., Berti, A., D’Amico, M., Sabatelli, N., Guzzardi, F., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105606 · Cited by 16
Jiang, X., Wang, H., Nie, K., Gao, Y., Shen, C., Tang, Y., Wang, Z., Su, H., & Dong, H. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00988-w · Cited by 17
A Rare Case of Tirzepatide-Induced Hepatotoxicity
Sohal, A., Casanova, L., & Kowdley, K. V. (2024) · ACG Case Reports Journal · doi:10.14309/crj.0000000000001484 · Cited by 16
Elsabaawy, M. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01493-y · Cited by 18
“The global increase in obesity has led to a surge in metabolic disorders, with chronic liver disease being a major outcome [1].”
BackgroundDepalmitoylation and cell physiology: APT1 as a mediator of metabolic signals
Speck, S. L., Wei, X., & Semenkovich, C. F. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00542.2023 · Cited by 15
Colton, E., Connors, M., Mahlberg, J., & Verdejo‐García, A. (2024) · Obesity Reviews · doi:10.1111/obr.13801 · Cited by 17
Mohan, D. M., Anouti, F. A., Kohli, N., & Khalaf, K. A. (2025) · International Journal of Obesity · doi:10.1038/s41366-025-01881-8 · Cited by 19
“However, in societies with higher income levels, there is a prevailing social stigma surrounding obesity, in addition to access to healthy diets, healthcare, education, and weight loss-promoting activities, which further ampli fi es the disparities in obesity rates [63].”
Genome-Wide Association Study of Exercise-Induced Fat Loss Efficiency
Bojarczuk, A., Boulygina, E. A., Dzitkowska-Zabielska, M., Łubkowska, B., Leońska‐Duniec, A., Egorova, E. S., Semenova, E. A., Andryushchenko, L. B., Larin, A. K., Generozov, E. V., et al. (2022) · Genes · doi:10.3390/genes13111975 · Cited by 16
“7 billion adults will be overweight and over 1 billion will be obese by 2025 [1].”
BackgroundGao, J., Zhang, Z., Dong, X., Jing, Z., Peng, Z., Zhang, L., Xu, Z., Xu, L., Wang, X., & Guo, X. (2023) · The FASEB Journal · doi:10.1096/fj.202301166r · Cited by 15
Zmerly, H., Milanese, C., Ghoch, M. E., Itani, L., Tannir, H., Kreidieh, D., Yumuk, V., & Pellegrini, M. (2023) · Diseases · doi:10.3390/diseases11040182 · Cited by 17
“According to the World Health Organization, in 2022, there were approximately 650 million adults globally with obesity, and the World Obesity Federation estimates that by 2030, one in five women and one in seven men will be affected by obesity [4].”
BackgroundAli, S., Baig, S., Wanninayake, S., Xavier, G. D. S., Dawson, C., Paisey, R., & Geberhiwot, T. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15398 · Cited by 16
Dinu, M., Lotti, S., Pagliai, G., Napoletano, A., Asensi, M. T., Giangrandi, I., Marcucci, R., Amedei, A., Colombini, B., & Sofi, F. (2024) · Trials · doi:10.1186/s13063-024-07996-z · Cited by 15
“In recent years, the prevalence of overweight and obesity has reached epidemic proportions [1], posing significant challenges to public health worldwide [2].”
BackgroundDamigou, E., Georgoulis, M., Chrysohoou, C. A., Barkas, F., Vlachopoulou, E., Adamidis, P. S., Kravvariti, E., Tsioufis, C. P., Pitsavos, C. E., Liberopoulos, E. N., et al. (2024) · Nutrients · doi:10.3390/nu16081128 · Cited by 17
Vick, L. V., Rosario, S. R., Riess, J. W., Canter, R. J., Mukherjee, S., Monjazeb, A. M., & Murphy, W. J. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00007-4 · Cited by 15
Duan, Y., & Lu, G. (2024) · Journal of Sports Science and Medicine · doi:10.52082/jssm.2024.495 · Cited by 14
Yang, T., Yang, L., Liao, L., Xie, C., Mo, X., Cai, D., Peng, T., Xiao, Y., Liu, C., Li, Q., et al. (2025) · Hepatology International · doi:10.1007/s12072-025-10782-x · Cited by 15
“Our findings indicated that NAFLD–NASH–NALC is emerging as a new development pathway for hepatocellular carcinoma due to global economic progress and changing dietary habits [12, 13].”
Wang, Q., Huang, Y., Meng, K., Zhang, H., Han, Y., Zhang, R., Han, X., Liu, G., Cai, H., & Yang, P. (2025) · Nutrients · doi:10.3390/nu17142346 · Cited by 14
Pereira, D. E., Tummala, S., Mittal, M. M., Obey, M. R., Berkes, M. B., McAndrew, C. M., & Wilson, J. L. (2025) · Injury · doi:10.1016/j.injury.2025.112746 · Cited by 15
GLP-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease
Alicic, R. Z., Neumiller, J. J., & Tuttle, K. R. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-025-01036-y · Cited by 18
Pediatric COVID-19 and Diabetes: An Investigation into the Intersection of Two Pandemics
Fotea, S., Ghiciuc, C. M., Ștefănescu, G., Cianga, A. L., Mihai, C. M., Lupu, A., Butnariu, L. I., Stârcea, I. M., Șalaru, D. L., Mocanu, A., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13142436 · Cited by 16
“The World Health Organization (WHO) reports that in America, Europe and the Eastern Mediterranean, roughly 50% of the population is classified as overweight or obese, with lower rates in Africa and Asia [62].”
BackgroundRad, Z. A., Mousavi, S. N., & Chiti, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-45054-x · Cited by 17
Boutari, C., Stefanakis, K., Simati, S., Guatibonza-García, V., Valenzuela‐Vallejo, L., Anastasiou, I. A., Connelly, M. A., Kokkinos, A. D., & Mantzoros, C. S. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02264-5 · Cited by 14
Self-citationTalay, L., & Vickers, M. (2024) · Behavioral Sciences · doi:10.3390/bs14060480 · Cited by 13
“Obesity is a chronic disease that has reached epidemic proportions in Australia and many other countries throughout the world [1].”
BackgroundDehghani, A., Molani‐Gol, R., Mohammadi-Narab, M., Norouzy, A., Abolhassani, M. H., Jabali, S. M. T., Pazouki, A., Soheilipour, F., & Mohammadi-Nasrabadi, F. (2024) · BMC Public Health · doi:10.1186/s12889-024-20860-8 · Cited by 15
“Similarly, the Southeast Asian region, starting at 0.9% in 1980, experienced a larger jump to 7.9% by 2019 [12].”
InfluentialPalumbo, A. M., Jacob, C. M., Khademioore, S., Sakib, M. N., Yoshida‐Montezuma, Y., Christodoulakis, N., Yassa, P., Vanama, M. S., Gamra, S., Ho, P., et al. (2025) · Obesity Reviews · doi:10.1111/obr.13894 · Cited by 15
Balkrishna, A., Sharma, S., Maity, M., Tomer, M., Singh, R., Gohel, V., Dev, R., Sinha, S., & Varshney, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114785 · Cited by 14
Mohammadi, M., Mohammadi, A., Habibzadeh, A., Korkorian, R., Mohamadi, M., Shaygannejad, V., Zabeti, A., & Mirmosayyeb, O. (2024) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2024.11.005 · Cited by 15
Martínez‐Montoro, J. I., Bandera-Merchán, B., Gutiérrez‐Bedmar, M., Gómez‐Pérez, A. M., Macías‐González, M., Moreno‐Indias, I., & Tinahones, F. J. (2025) · BMC Medicine · doi:10.1186/s12916-025-04182-z · Cited by 13
“The prevalence of overweight and obesity is increasing globally, having nearly tripled in the last few decades, and reaching epidemic dimensions worldwide [1].”
He, X., Su, J., Wang, K., Liang, Y., & Wang, L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329336 · Cited by 15
“In high-SDI settings, age-appropriate interventions should prioritize modifiable risk factors such as obesity, sedentary behavior, and delayed childbearing [78].”
Reitz, J., Rosoff, D. B., Perlstein, T., Wagner, A., Jung, J., Wagner, J., Reiner, B. C., & Lohoff, F. W. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03199-3 · Cited by 16
Grocic, M., Nguyen, M., & Sanyal, A. J. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70662 · Cited by 16
Gheorghe, L., Nemțeanu, R., Clim, A., Botnariu, G. E., Costache, I. I., & Pleşa, A. (2023) · Life · doi:10.3390/life13040857 · Cited by 14
“By 2030 it is predicted that one in five women and one in seven men will be living with obesity, resulting in over 1 billion people globally [3,4].”
BackgroundAmerikanou, C., Valsamidou, E., Kleftaki, S.-A., Gioxari, A., Koutoulogenis, K., Aroutiounova, M., Stergiou, I., & Kaliora, A. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1197648 · Cited by 14
“A similar pattern (Table 3) was detected when the levels of the above markers were compared with the number of metabolic components of MS that were present in the study population (central obesity plus; hypertension (2), hyperglycemia (3), hyperlipidemia (4)).”
Result
Metadata
- Authors
- Boutari, C., & Mantzoros, C. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Mantzoros, Christos S.
- Venue
- Metabolism
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 133
- Pages
- 155217
- ISSN
- 0026-0495 (ISSN-L)
- PMC
- PMC9107388
- OpenAlex
- W4280507423
- Cited by
- 1,068
- References
- 53
- Citations by year
- 2026: 176 · 2025: 331 · 2024: 344 · 2023: 188 · 2022: 27
- FWCI
- 196.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Metabolism (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, overweight, obesity prevalence, obesity epidemiology, obesity epidemic, COVID-19 pandemic, sex differences in obesity, age-standardized prevalence, Global Burden of Disease Study, sedentary lifestyle, unhealthy diet, obesity-related comorbidities, diabetes mellitus, non-alcoholic fatty liver disease, cardiovascular disease, obesity prevention policy
- MeSH terms
- COVID-19, Aged, Female, Humans, Male, Middle Aged, Obesity, Body Mass Index, Prevalence, Overweight, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
